DekaBank Deutsche Girozentrale’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.14M | Hold |
30,000
| – | – | 0.01% | 560 |
|
2025
Q1 | $4.57M | Hold |
30,000
| – | – | 0.01% | 581 |
|
2024
Q4 | $4.11M | Hold |
30,000
| – | – | 0.01% | 614 |
|
2024
Q3 | $4.32M | Hold |
30,000
| – | – | 0.01% | 616 |
|
2024
Q2 | $4.05M | Hold |
30,000
| – | – | 0.01% | 624 |
|
2024
Q1 | $4.44M | Hold |
30,000
| – | – | 0.01% | 603 |
|
2023
Q4 | $3.81M | Hold |
30,000
| – | – | 0.01% | 637 |
|
2023
Q3 | $2.84M | Hold |
30,000
| – | – | 0.01% | 665 |
|
2023
Q2 | $2.64M | Buy |
30,000
+10,000
| +50% | +$878K | 0.01% | 690 |
|
2023
Q1 | $2.15M | Hold |
20,000
| – | – | 0.01% | 711 |
|
2022
Q4 | $2.41M | Hold |
20,000
| – | – | 0.01% | 681 |
|
2022
Q3 | $2.04M | Buy |
20,000
+4,940
| +33% | +$503K | 0.01% | 701 |
|
2022
Q2 | $1.39M | Sell |
15,060
-9,000
| -37% | -$832K | ﹤0.01% | 801 |
|
2022
Q1 | $2.79M | Buy |
24,060
+2,200
| +10% | +$255K | 0.01% | 686 |
|
2021
Q4 | $2.9M | Buy |
21,860
+590
| +3% | +$78.3K | 0.01% | 693 |
|
2021
Q3 | $3.33M | Hold |
21,270
| – | – | 0.01% | 627 |
|
2021
Q2 | $2.83M | Hold |
21,270
| – | – | 0.01% | 654 |
|
2021
Q1 | $2.73M | Buy |
21,270
+10,000
| +89% | +$1.28M | 0.01% | 626 |
|
2020
Q4 | $1.89M | Sell |
11,270
-560
| -5% | -$93.7K | 0.01% | 682 |
|
2020
Q3 | $1.8M | Buy |
+11,830
| New | +$1.8M | 0.01% | 611 |
|
2019
Q3 | – | Sell |
-14,000
| Closed | -$1.52M | – | 999 |
|
2019
Q2 | $1.52M | Sell |
14,000
-13,100
| -48% | -$1.42M | 0.01% | 696 |
|
2019
Q1 | $1.92M | Buy |
27,100
+4,950
| +22% | +$350K | 0.01% | 620 |
|
2018
Q4 | $1.35M | Sell |
22,150
-4,950
| -18% | -$301K | 0.01% | 616 |
|
2018
Q3 | $1.92M | Buy |
27,100
+22,300
| +465% | +$1.58M | 0.01% | 633 |
|
2018
Q2 | $315K | Sell |
4,800
-16,000
| -77% | -$1.05M | ﹤0.01% | 990 |
|
2018
Q1 | $1.32M | Buy |
+20,800
| New | +$1.32M | 0.01% | 655 |
|